31 studies found for:    " April 23, 2008":" May 23, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" April 23, 2008":" May 23, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection
Condition: HIV Infections
Interventions: Biological: MVA-B;   Biological: Placebo
2 Completed
Has Results
Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay
Conditions: Healthy Donors;   HIV Positive
Intervention: Device: collection of follow-up sample based on PRISM HIV O Plus result
3 Completed Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)
Conditions: Hepatitis B;   HIV Infection
Intervention: Biological: GenHevac-B
4 Completed Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir
5 Terminated
Has Results
Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures
Conditions: Non-alcoholic Steatohepatitis;   Chronic Liver Disease;   HCV;   NASH.;   HIV Infection;   Thrombocytopenia;   Hepatitis C Virus;   HBV;   Human Immunodeficiency Virus;   Liver Diseases;   Hepatitis B Virus
Interventions: Drug: Eltrombopag;   Drug: Placebo
6 Active, not recruiting Prospective Observational Epidemiologic Study of Maraviroc's Safety
Condition: Human Immunodeficiency Virus
Interventions: Drug: Maraviroc along with an optimized background antiretroviral drug regimen;   Drug: Optimized background antiretroviral drug regimen without maraviroc
7 Completed Phase II Study of AGS‑004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV
Condition: HIV Infections
Intervention: Biological: AGS-004
8 Terminated Kaletra and Viread in Antiretroviral Naïve Patients
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir and tenofovir
9 Suspended Bioequivalence Study of Didanosine in Children Treated for HIV
Condition: HIV Infections
Intervention: Drug: didanosine
10 Completed Preventing HIV/Aids in Drug Abusing Youth
Condition: HIV Infections
Interventions: Behavioral: IBFT /HIV prevention;   Behavioral: IBFT
11 Completed Rapid HIV Testing for Emergency Department Patients
Condition: HIV Infections
Intervention: Behavioral: HIV risk education
12 Completed HIV Vertical Transmission in Vietnam
Condition: HIV Infections
Intervention:
13 Completed Pilot Trial of a Synbiotic in HIV+ Patients
Condition: HIV Infection
Interventions: Dietary Supplement: Synbiotic 2000;   Dietary Supplement: Placebo
14 Completed HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain
Condition: HIV Infections
Intervention: Drug: Salvage antiretroviral therapy including raltegravir
15 Completed
Has Results
Qualitative Assessment of Implementing Routine Rapid HIV Testing
Condition: HIV Infections
Intervention:
16 Completed Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Tenofovir/Emtricitabine
17 Completed Impact of Peer Health Workers and Mobile Phones on HIV Care
Condition: HIV Infections
Interventions: Behavioral: Peer Health Workers Intervention;   Behavioral: Peer Health Workers and Mobile Phone Intervention
18 Unknown  Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda
Condition: HIV Infections
Interventions: Drug: cotrimoxazole;   Drug: Placebo
19 Completed Enhancing Communication and HIV Outcomes
Condition: HIV Infections
Intervention: Behavioral: communication training
20 Completed A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP
Condition: HIV Infections
Intervention: Drug: AZT/3TC/NVP, AZT/D4T/NVP, Truvada/NVP

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Indicates status has not been verified in more than two years